Tech Mahindra planning to start trials for COVID drug in next three to four months

11 Aug 2021 Evaluate

Tech Mahindra is planning to start trials for a COVID drug in the next three to four months after receiving the patent for a particular molecule. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for a patent for a molecule that can be used to develop a drug against coronavirus.

Tech Mahindra represents the connected world, offering innovative and customer-centric information technology experiences, enabling Enterprises, Associates and the Society to Rise.

Tech Mahindra Share Price

1670.55 82.05 (5.17%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3206.70
Infosys 1689.40
HCL Tech. 1698.90
Wipro 267.25
Tech Mahindra 1670.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×